What does this research mean for the field?

Sarcopenia combined with elevated lipid parameters significantly increases the risk of cardiovascular disease in middle-aged and older adults, particularly in those with normal glucose regulation and prediabetes. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

The aim is to explore how sarcopenia and lipid levels together influence cardiovascular disease risk in individuals with varying glucose metabolism.

March 10, 2026Geriatrics and gerontology international/Geriatrics & gerontology international

Joint Assessment of Sarcopenia and Lipid Parameters on Cardiovascular Diseases in Middle‐Aged and Older Adults in China With Different Glucose Metabolism Status

View Full Paper

Ask AI

Bookmark

Authors

WLWei LuoUppsala University YXY XuZhongda Hospital Southeast University ZTZaixiao TaoZhongda Hospital Southeast University

Discussion

Member takes

Implication

Observational study examines the impact of sarcopenia and lipid factors on cardiovascular disease risk across glucose metabolism statuses, suggesting new risk assessment approaches.

Key Points

The aim is to explore how sarcopenia and lipid levels together influence cardiovascular disease risk in individuals with varying glucose metabolism.
Included 9053 participants aged 45 and older from the China Health and Retirement Longitudinal Study (CHARLS) 2015 without prior cardiovascular disease.
Employed multivariable logistic regression to assess connections between sarcopenia, lipid levels, and cardiovascular events, stratified by glucose metabolism.
Implemented restricted cubic splines to analyze non-linear relationships between lipid metrics and cardiovascular disease.
Used receiver operating characteristic curves (ROC) to evaluate the predictive accuracy of lipid metrics.
11.9% of participants reported new-onset cardiovascular disease.
Synergistic effects of sarcopenia and elevated lipid levels increased cardiovascular disease risk, especially in individuals with normal glucose and prediabetes.
Non-traditional lipid indices were shown to have modest accuracy compared to standard measures across different glucose metabolism states.
The atherogenic coefficient showed limited but consistent predictive value for cardiovascular disease risk across glucose metabolism states.

Cite This Study

Luo et al. (2026) studied this question.

synapsesocial.com/papers/69af95de70916d39fea4ded7 https://doi.org/10.1111/ggi.70411

View Full Paper

Ask AI

Bookmark

Implication

Observational study examines the impact of sarcopenia and lipid factors on cardiovascular disease risk across glucose metabolism statuses, suggesting new risk assessment approaches.

Joint Assessment of Sarcopenia and Lipid Parameters on Cardiovascular Diseases in Middle‐Aged and Older Adults in China With Different Glucose Metabolism Status

Discussion

Member takes

Implication

Key Points

Cite This Study

Joint Assessment of Sarcopenia and Lipid Parameters on Cardiovascular Diseases in Middle‐Aged and Older Adults in China With Different Glucose Metabolism Status

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider